(Q84965476)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20803081%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

title

mTOR signaling is involved in indomethacin and nimesulide suppression of colorectal cancer cell growth via a COX-2 independent pathway (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20803081%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

mTOR Signaling is Involved in Indomethacin and Nimesulide Suppression of Colorectal Cancer Cell Growth via a COX-2 Independent Pathway (English)

1 reference

https://api.crossref.org/works/10.1245/S10434-010-1268-9

3 July 2024

1 reference

0 references

1 reference

Yan-Jie Zhang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20803081%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Yu-Jie Bao

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20803081%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Qiang Dai

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20803081%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Wen-Yan Yang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20803081%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Peng Cheng

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20803081%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Li-Ming Zhu

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20803081%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Bi-Jun Wang

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20803081%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Fo-Hu Jiang

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20803081%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20803081

3 July 2024

publication date

28 August 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20803081%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

13 February 2020

http://www.annalssurgicaloncology.org/cgi/content/abstract/18/2/580

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20803081

http://link.springer.com/content/pdf/10.1245/s10434-010-1268-9.pdf

3 July 2024

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1245/S10434-010-1268-9

http://link.springer.com/article/10.1245/s10434-010-1268-9/fulltext.html

3 July 2024

1 reference

https://api.crossref.org/works/10.1245/S10434-010-1268-9

http://link.springer.com/content/pdf/10.1245/s10434-010-1268-9

3 July 2024

1 reference

https://api.crossref.org/works/10.1245/S10434-010-1268-9

Annals of Surgical Oncology

3 July 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20803081%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20803081%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20803081%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

page(s)

580-588

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20803081%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1245/s10434-010-1268-9

13 February 2020

exact match

0 references

cites work

TOR-in(g) the nucleus

1

1 reference

https://api.crossref.org/works/10.1245/S10434-010-1268-9

Upstream and downstream of mTOR

3 July 2024

2

1 reference

https://api.crossref.org/works/10.1245/S10434-010-1268-9

Defining the role of mTOR in cancer

3 July 2024

3

1 reference

https://api.crossref.org/works/10.1245/S10434-010-1268-9

Targeting mammalian target of rapamycin (mTOR) for health and diseases.

3 July 2024

4

1 reference

https://api.crossref.org/works/10.1245/S10434-010-1268-9

Mammalian target of rapamycin: discovery of rapamycin reveals a signaling pathway important for normal and cancer cell growth

3 July 2024

5

1 reference

https://api.crossref.org/works/10.1245/S10434-010-1268-9

mTOR signaling pathway is a target for the treatment of colorectal cancer.

3 July 2024

6

1 reference

https://api.crossref.org/works/10.1245/S10434-010-1268-9

Combined inhibition of MEK and mTOR signaling inhibits initiation and progression of colorectal cancer

3 July 2024

7

1 reference

https://api.crossref.org/works/10.1245/S10434-010-1268-9

Back to the future: COX-2 inhibitors for chemoprevention and cancer therapy

3 July 2024

8

1 reference

https://api.crossref.org/works/10.1245/S10434-010-1268-9

Cyclooxygenase-2 (COX-2)-independent anticarcinogenic effects of selective COX-2 inhibitors

3 July 2024

9

1 reference

https://api.crossref.org/works/10.1245/S10434-010-1268-9

Non-COX-2 targets and cancer: expanding the molecular target repertoire of chemoprevention

3 July 2024

10

1 reference

https://api.crossref.org/works/10.1245/S10434-010-1268-9

3 July 2024

NSAIDs and apoptosis

11

1 reference

https://api.crossref.org/works/10.1245/S10434-010-1268-9

COX-2 suppresses tissue factor expression via endocannabinoid-directed PPARdelta activation

3 July 2024

12

1 reference

https://api.crossref.org/works/10.1245/S10434-010-1268-9

Susceptibility for NSAIDs-induced apoptosis correlates to p53 gene status in gastric cancer cells

3 July 2024

14

1 reference

https://api.crossref.org/works/10.1245/S10434-010-1268-9

The cyclooxygenase-2 inhibitor nimesulide, a nonsteroidal analgesic, decreases the effect of radiation therapy in head-and-neck cancer cells

3 July 2024

15

1 reference

https://api.crossref.org/works/10.1245/S10434-010-1268-9

Effect of a selective cyclooxygenase-2 inhibitor, nimesulide, on the growth of lung tumors and their expression of cyclooxygenase-2 and peroxisome proliferator- activated receptor-gamma

3 July 2024

16

1 reference

https://api.crossref.org/works/10.1245/S10434-010-1268-9

Combined inhibition of Dnmt and mTOR signaling inhibits formation and growth of colorectal cancer

3 July 2024

17

1 reference

https://api.crossref.org/works/10.1245/S10434-010-1268-9

Stimulation of cyclooxygenase-2 expression by bone-derived transforming growth factor-beta enhances bone metastases in breast cancer

3 July 2024

18

1 reference

https://api.crossref.org/works/10.1245/S10434-010-1268-9

Inhibition of human neuroblastoma in SCID mice by low-dose of selective Cox-2 inhibitor nimesulide

3 July 2024

19

1 reference

https://api.crossref.org/works/10.1245/S10434-010-1268-9

Common corruption of the mTOR signaling network in human tumors

3 July 2024

21

1 reference

https://api.crossref.org/works/10.1245/S10434-010-1268-9

Evaluating temsirolimus activity in multiple tumors: a review of clinical trials

3 July 2024

23

1 reference

https://api.crossref.org/works/10.1245/S10434-010-1268-9

Methylnaltrexone potentiates the anti-angiogenic effects of mTOR inhibitors

3 July 2024

24

1 reference

https://api.crossref.org/works/10.1245/S10434-010-1268-9

Downregulation of Notch pathway by a gamma-secretase inhibitor attenuates AKT/mammalian target of rapamycin signaling and glucose uptake in an ERBB2 transgenic breast cancer model.

3 July 2024

25

1 reference

https://api.crossref.org/works/10.1245/S10434-010-1268-9

Cyclooxygenase-2 promotes hepatocellular carcinoma cell growth through Akt activation: evidence for Akt inhibition in celecoxib-induced apoptosis

3 July 2024

26

1 reference

https://api.crossref.org/works/10.1245/S10434-010-1268-9

E2F1 inhibits c-Myc-driven apoptosis via PIK3CA/Akt/mTOR and COX-2 in a mouse model of human liver cancer

3 July 2024

27

1 reference

https://api.crossref.org/works/10.1245/S10434-010-1268-9